# Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition

> **NCT06132269** · NA · COMPLETED · sponsor: **TCI Co., Ltd.** · enrollment: 70 (actual)

## Conditions studied

- Body Weight Changes
- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** AKK formula prebiotic sachet
- **DIETARY_SUPPLEMENT:** Placebo sachet

## Key facts

- **NCT ID:** NCT06132269
- **Lead sponsor:** TCI Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-09
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-05-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06132269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06132269, "Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06132269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*